Saladax Expands Global Access to Drug Monitoring Tests
BETHLEHEM, PA, April 7, 2026 Saladax Biomedical, Inc. has announced a strategic distribution agreement with Thermo Fisher Scientific to...
Clinical Diagnostics
Advertisement
Early mNGS Testing Cuts Diagnosis Time in CNS Infections
BOSTON, January 22, 2026 — Delve Bio announced new clinical evidence demonstrating that earlier use of metagenomic next-generation sequencing...
Singlera–Pitt Advance Early Pancreatic Cancer Detection
LA JOLLA, Calif., Dec. 17, 2025 — Singlera Genomics announced a strategic research collaboration with the University of Pittsburgh...
Meta-Analysis Validates TissueCypher for Esophageal Cancer Risk
FRIENDSWOOD, Texas — December 12, 2025 — Castle Biosciences, Inc., a diagnostics company advancing precision medicine in gastroenterology, announced...
Exagen Inc. Showcases Autoimmune Diagnostic Leadership at Q4 2025 Conferences
Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...
Advertisements
Tosoh Bioscience Gains FDA 510(k) Clearance for Rapid GR01 HbA1c Analyzer
Grove City, Ohio – October 30, 2025 — Tosoh Bioscience, Inc., a global leader in clinical diagnostics and laboratory...
GeneseeqPrime Gains FDA 510(k) Clearance for Tumor Profiling Kit
TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...
Advertisement
